Differential Effects of Integrin Blockade on Gut and Sacroiliac Joint Inflammation

αβ is a prototypic gut integrin that regulates homing of memory and effector T cells to the gut. Vedolizumab is an anti-αβ monoclonal antibody and is approved by the US Food and Drug Administration to treat ulcerative colitis and Crohn disease (CD). .